tropolone has been researched along with 2019 Novel Coronavirus Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, B; Hoang, BX | 1 |
| Bhuvanesh, N; Darensbourg, MY; DeLaney, C; Fierke, CF; Liu, WR; Pectol, DC; Salas, I; Sheng, Y; Vantansever, E; Zhang, H | 1 |
2 other study(ies) available for tropolone and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
A possible application of hinokitiol as a natural zinc ionophore and anti-infective agent for the prevention and treatment of COVID-19 and viral infections.
Topics: Anti-Infective Agents; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Homeostasis; Humans; Hydroxychloroquine; Ionophores; Models, Theoretical; Monoterpenes; Risk; Tropolone; Zinc | 2020 |
Zinc thiotropolone combinations as inhibitors of the SARS-CoV-2 main protease.
Topics: Antiviral Agents; Catalytic Domain; Coronavirus 3C Proteases; COVID-19; COVID-19 Drug Treatment; Humans; Ligands; Models, Molecular; Molecular Docking Simulation; Protease Inhibitors; SARS-CoV-2; Tropolone; Zinc | 2021 |